TRANSGENE (Paris: TNG) today announced that its Universal registration document for the fiscal year ended December 31, 2023, was submitted to the French stock market authority (Autorité des Marchés financiers – AMF) in ESEF format and registered under the reference D.24-0274.
The 2023 Universal Registration Document is available to the public under the conditions provided by applicable regulations. The document is available on the Company’s website: www.transgene.fr, in the “Investors/Financial information” section and on the AMF website: www.amf-france.org.
It includes:
- the 2023 annual financial report;
- the report of the Board of Directors on corporate governance;
- the statutory auditor’s reports;
- information on the share buyback program;
- information related on the auditor’s fees.
The universal registration document also includes information on the Company’s environmental and social responsibility.
Contacts
| Transgene: Lucie Larguier Chief Financial Officer +33 (0)3 88 27 91 04 investorrelations@transgene.fr |
Attachment
